Vaccine Development for STDS

The consistent use of condoms will reduce the risk of contracting and spreading HPV infections. The HPV2 and HPV4 vaccines (e.g., Gardasil, Cervarix) are recommended for the immunization of both males and females.

The Advisory Committee on Immunization Practices (ACIP) recommends either vaccine for routine use in females ages 11 or 12 years. Ideally, the vaccination should be given before a girl or woman has become sexually active because it does not protect against existing HPV infections. The current HPV vaccine does not protect against all potentially cancer-causing types of HPV. Therefore, all women—even those who have been vaccinated against HPV—should have regular Pap tests.

  • Hepatitis B Vaccines
  •  Genital Herpes Vaccines
  • HIV Vaccines
  • Gonorrhea and Chlamydia Vaccines
  • Hepatitis A
  • Human Papilomavirus (HPV) Vaccine
  • Hepatitis B
  • Influenza (Flu) vaccine
  • Pneumococcal Vaccine
  • Tetanus Vaccine
  • Diphtheria Vaccine
  • Pertussis Vaccine
  • Varicella Vaccine
  • Zoster Vaccine
  • Polio Vaccine
  • Measles Vaccine
  • Mumps Vaccine
  • Rubella Vaccine

Related Conference of Vaccine Development for STDS

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic

Vaccine Development for STDS Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in